Most Recent
Consumer goods giant Reckitt Benckiser has successfully opposed a proposed patent for a toilet bowl cleaner filed by rival S.C. Johnson, but a delegate for IP Australia has allowed the company to amend its patent application.
The company that manufactures Botox alternatives has denied infringing on Allergan's Botox trade mark, telling a court Wednesday its use of the word was for comparative purposes only.
Discount supermarket chain Aldi offered $150,000 to end a lawsuit brought by the maker of the popular MoroccanOil line of hair products, a court judgment revealed Tuesday.
Ophthalmic diagnostic device manufacturer ObjectiVision has made its final pitch to the Federal Court at the end of trial in a long-running intellectual property and contract dispute with the University of Sydney, saying in closing submissions that the school had run a "curious" case.
Microsoft has won a $2.8 million judgment against a Melbourne computer retailer for violating the intellectual property for its Windows 7 software.
Chinese tech company Hytera Communications Corporation has been ordered to hand over source code for all radio devices at the heart of a international patent dispute with Motorola Solutions.
Generic drug maker Alphapharm is fighting a bid by global pharmaceutical giant Sanofi-Aventis to block the listing of one of its injector pens, saying the proposed injunction should be denied because Sanofi is seeking to amend the patent at issue.
A judge has denied a bid for a strict regime for dealing with confidential information in a lawsuit between cheese giants Fonterra and Bega over alleged violations of the terms of a trade mark licensing agreement.
A judge has found two patents held by an Eli Lilly & Co. unit for erectile dysfunction drug Cialis are valid and that generic manufacturer Apotex threatened to infringe the patents.
US-based Millennium Pharmaceuticals has secured a temporary injunction that bans generic drug maker Juno Pharmaceuticals from importing or selling its cheap version of breakthrough cancer drug Velcade in Australia.